Yasmin Sheikh, head of policy and public affairs at Anthony Nolan, said: “At Anthony Nolan, we’ve seen how transformative CAR T-cell therapy can be for people with blood cancer.
“We’re very excited to see these results which highlight the potential for CAR T-cell therapy to also benefit people living with autoimmune conditions.
“While these findings are highly encouraging, attention must turn to how these innovative treatments can be delivered in practice.
“The NHS must ensure that it has the workforce and infrastructure in place so that patients can benefit from these new therapies without delay.”
Contact details are available to account holders.
Create a free account to get in touch with this expert.